SFFS
MRNA icon

Stonehage Fleming Financial Services’s Moderna MRNA Stock Holding History

Stonehage Fleming Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,250
Closed -$147K – 193
2022
Q3 		$147K Buy
+1,250
New +$190K 0.01% 107
2022
Q1 		– Sell
-500
Closed -$126K – 230
2021
Q4 		$126K Sell
500
-200
-29% -$58.5K ﹤0.01% 170
2021
Q3 		$269K Hold
700
– – 0.01% 143
2021
Q2 		$164K Sell
700
-1,500
-68% -$268K ﹤0.01% 145
2021
Q1 		$288K Buy
2,200
+400
+22% +$58K 0.01% 134
2020
Q4 		$188K Buy
+1,800
New +$182K 0.01% 141

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stonehage Fleming Financial Services's MRNA Position: Q4 2022 in Review

Stonehage Fleming Financial Services sold out of Moderna (MRNA) in Q4 2022, closing a stake of 1,250 shares — an estimated $147K sold.

Stonehage Fleming Financial Services first reported a position in MRNA in Q4 2020 and held it in 6 quarters. The position peaked at $288K in Q1 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Stonehage Fleming Financial Services reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 1,250 Moderna shares in Q4 2022, an estimated $147K.
  • Stonehage Fleming Financial Services first reported a position in Moderna in Q4 2020 and held it in 6 quarters.
  • Stonehage Fleming Financial Services's Moderna position peaked at $288K in Q1 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Stonehage Fleming Financial Services's 13F filing for Q4 2022, filed 14 Feb 2023.